Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
TEVA
TEVA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TEVA News
Teva Pharmaceutical Featured in Einhorn's Top Stock Picks
10h ago
Yahoo Finance
Teva's FDA Approval of Long-Acting Drug Could Be Major Catalyst
1d ago
NASDAQ.COM
Teva Pharmaceutical Shares Surge 130% with Optimistic Outlook
1d ago
Fool
Greenlight Capital Achieves 6.5% Return in Q1 Amid Market Decline
5d ago
seekingalpha
ACWX ETF 52-Week Price Analysis
Apr 08 2026
NASDAQ.COM
Biotech Landscape Update: Regulatory Approvals and Acquisitions
Apr 03 2026
NASDAQ.COM
Teva Receives FDA Approval for New Biosimilar Drug
Mar 30 2026
seekingalpha
Analysis of FNDF ETF's 52-Week Price Range
Mar 30 2026
NASDAQ.COM
Teva Receives FDA Approval for New Biosimilar
Mar 30 2026
NASDAQ.COM
Teva's Biosimilar PONLIMSI Receives FDA Approval
Mar 30 2026
Newsfilter
TEVA ACHIEVES BIOSIMILAR PROGRESS WITH U.S. FDA APPROVAL OF PONLIMSI™ (DENOSUMAB-ADET) AND ACCEPTANCE OF DUAL FILING FOR BIOSIMILAR CANDIDATE TO XOLAIR® (OMALIZUMAB)
Mar 30 2026
moomoo
FNDF ETF 52-Week Price Analysis
Mar 20 2026
NASDAQ.COM
Concerns Rise Over Generic Drug Supply Shortages in the U.S.
Mar 16 2026
seekingalpha
ProShares Short MSCI EAFE ETF Sees 36.6% Inflow Surge
Mar 11 2026
NASDAQ.COM
Long-Term Investment Opportunities Amid Market Volatility
Mar 06 2026
Fool
Comparing Turnarounds: Pfizer vs. Teva
Mar 04 2026
Fool
Show More News
